This volume presents the most complicated and powerful cancer biotherapies developed. It provides an overview of human immune system function and the mechanisms by which adoptive cellular immunotherapies (ACI) harnesses the activity. The volume provides a vision on the developments in ACI.
This volume presents the most complicated and powerful cancer biotherapies developed. It provides an overview of human immune system function and the mechanisms by which adoptive cellular immunotherapies (ACI) harnesses the activity. The volume provides a vision on the developments in ACI.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
1. Adoptive Cellular Immunotherapy of Cancer: An Overview 2. Lymphokine-Activated Killer Lymphocytes: Evidence for Regulation of Induction and Function by Multiple Cytokines 3. Lymphokine-Activated Killer Lymphocytes: National Cancer Institute Clinical Trials 4. Lymphokine-Activated Killer Lymphocytes: Extramural Clinical Trials 5. Lymphokine-Activated Killer Lymphocytes: Biotherapeutics Clinical Trials 6. Lymphokine-Activated Killer Lymphocytes: LAK and Interleukin-2 in the Treatment of Malignancies of the Central Nervous System 7. Activated Killer Monocytes: Preclinical Model Systems 8. Activated Killer Monocytes: Use in Clinical Trials 9. Tumor-Infiltrating Lymphocytes: Antigen-Specific Killer T-Lymphocytes or Activated Natural Killer Lymphocytes? 10. Tumor-Derived Activated Cells: Culture Conditions and Characterization 11. Clinical/Technical Challenges in Adoptive Cellular Immunotherapy: The Role of Cytapheresis 12. Clinical/Technical Challenges in Adoptive Cellular Immunotherapy : In Vitro Culture Techniques 13. Clinical/Technical Challenges in Adoptive Cellular Immunotherapy: Role of Nurses, Technicians, and Other Support Personnel 14. Adoptive Cellular Immunotherapy of Cancer: Future Perspectives
1. Adoptive Cellular Immunotherapy of Cancer: An Overview 2. Lymphokine-Activated Killer Lymphocytes: Evidence for Regulation of Induction and Function by Multiple Cytokines 3. Lymphokine-Activated Killer Lymphocytes: National Cancer Institute Clinical Trials 4. Lymphokine-Activated Killer Lymphocytes: Extramural Clinical Trials 5. Lymphokine-Activated Killer Lymphocytes: Biotherapeutics Clinical Trials 6. Lymphokine-Activated Killer Lymphocytes: LAK and Interleukin-2 in the Treatment of Malignancies of the Central Nervous System 7. Activated Killer Monocytes: Preclinical Model Systems 8. Activated Killer Monocytes: Use in Clinical Trials 9. Tumor-Infiltrating Lymphocytes: Antigen-Specific Killer T-Lymphocytes or Activated Natural Killer Lymphocytes? 10. Tumor-Derived Activated Cells: Culture Conditions and Characterization 11. Clinical/Technical Challenges in Adoptive Cellular Immunotherapy: The Role of Cytapheresis 12. Clinical/Technical Challenges in Adoptive Cellular Immunotherapy : In Vitro Culture Techniques 13. Clinical/Technical Challenges in Adoptive Cellular Immunotherapy: Role of Nurses, Technicians, and Other Support Personnel 14. Adoptive Cellular Immunotherapy of Cancer: Future Perspectives
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826